Trial intelligence / Profile preview

Fenofibrate for Microalbuminuria in Hypertriglyceridemic T2DM Patients

NCT02314533Phase 4Unknown

Sponsor
Beijing Chaoyang Hospital
Start
Dec 2014
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of fenofibrate in diabetic nephropathy (DN), sponsored by Beijing Chaoyang Hospital. Status: unknown.

02

Drugs

fenofibrate
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT02314533.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02314533.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call